Kosh Agarwal
0000-0002-4754-828X
404 papers found
Refreshing results…
Hbcrag and Pg HBV Rna Biomarkers Accurately Predict the Risk of Mother to Child HBV Transmission in a HBV Pan-Genotypic Cohort
Aetiology of delirium post liver transplant: The King's experience
Impact of Treatment With Tenofovir Alafenamide (Taf) or Tenofovir Disoproxil Fumarate (Tdf) on Hepatocellular Carcinoma (Hcc) Incidence in Patients With Chronic Hepatitis B (Chb)
Mreach-B Stratifies HCC Risk in a 'Real World', Multi-Ethnic Population, Including Sub Saharan Africans: Simplifying HCC Surveillance and Optimising Resource Usage
Analysis of Serum HBV Pgrna in a Large Cohort of Nucleos(t)ide Treated Patients Shows No Significant Differences Between Core and X Gene Quantitation
The Nonsteroidal Farnesoid X Receptor (Fxr) Agonist Cilofexor Improves Liver Biochemistry in Patients With Primary Biliary Cholangitis (Pbc): A Phase 2, Randomized, Placebo-Controlled Trial
The SECOND-GENERATION HEPATITIS B VIRUS (HBV) CORE INHIBITOR (CI) ABI-H2158 IS ASSOCIATED WITH POTENT ANTIVIRAL ACTIVITY IN a 14-Day MONOTHERAPY STUDY IN HBeAg-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis
Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy
Effects of Treatment of Chronic Hepatitis B Virus Infection on Patient-Reported Outcomes
Sofosbuvir/velpatasvir for 12 weeks in genotype 1–4 HCV-infected liver transplant recipients
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment
Achieving Cure From Hepatitis C Virus Is Good for More Than Just the Liver Graft
Glecaprevir/pibrentasvir treatment in liver or kidney transplant patients with hepatitis C virus infection
The road map toward an hepatitis C virus-free transplant population
Palliative care in end-stage liver disease: Time to do better?
Delineating the global challenges of hepatitis B virus infection
Reducing the Number of Measurements in Liver Point Shear-Wave Elastography: Factors that Influence the Number and Reliability of Measurements in Assessment of Liver Fibrosis in Clinical Practice
IDDF2018-ABS-0109 SOFOSBUVIR/VELPATASVIR for 12 weeks in genotype 1–4 hcv-infected liver transplant recipients
Efficacy and Tolerability of Direct‐Acting Antivirals for Hepatitis C in Older Adults
Missing publications? Search for publications with a matching author name.